across measures of positive and negative symptoms, global psychopathology, and functional outcomes (Perkins, Gu, Boteva, & Lieberman, 2005). Antipsychotic medication adherence has also been significantly associated with achieving recovery in patients with schizophrenia (Novick, Haro, Suarez, Vieta, & Naber, 2009).